Crossmark

Preoperative fractional exhaled nitric oxide is a risk and predictive factor of postoperative cough for early-stage non-small cell lung cancer patients: a longitudinal study

Crossref DOI link: https://doi.org/10.1186/s12890-024-03413-y

Published Online: 2024-12-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lin, Rongjia

Yu, Genmiao

Tu, Xiuhua
License Information

Text and Data Mining valid from 2024-12-02

Version of Record valid from 2024-12-02
More Information

Article History

Received: 20 November 2023

Accepted: 25 November 2024

First Online: 2 December 2024

Declarations

:

: This is part of a larger study which was approved by China Ethics Committee of Registering Clinical Trials (approval no. from the ethics committee: ChiECRCT20190084) and was approved by the Chinese Clinical Trial Registry (Clinicaltrials.gov number: ChiCTR1900023419). Due to the exploratory nature of the study, we have chosen to analyze data from patients with early-stage NSCLC in the above registry study. There will be some differences in exclusion criteria and sample size. The decision to respond to the questionnaire was considered as an informed consent. All methods were performed in accordance with the Declaration of Helsinki.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below